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ABSTRACT
RPA-coated single-stranded DNA (RPA–ssDNA), a
nucleoprotein structure induced by DNA damage,
promotes ATR activation and homologous recombi-
nation (HR). RPA is hyper-phosphorylated and ubiq-
uitylated after DNA damage. The ubiquitylation of
RPA by PRP19 and RFWD3 facilitates ATR activation
and HR, but how it is stimulated by DNA damage is
still unclear. Here, we show that RFWD3 binds RPA
constitutively, whereas PRP19 recognizes RPA after
DNA damage. The recruitment of PRP19 by RPA de-
pends on PIKK-mediated RPA phosphorylation and
a positively charged pocket in PRP19. An RPA32
mutant lacking phosphorylation sites fails to recruit
PRP19 and support RPA ubiquitylation. PRP19 mu-
tants unable to bind RPA or lacking ubiquitin ligase
activity also fail to support RPA ubiquitylation and
HR. These results suggest that RPA phosphorylation
enhances the recruitment of PRP19 to RPA–ssDNA
and stimulates RPA ubiquitylation through a process
requiring both PRP19 and RFWD3, thereby triggering
a phosphorylation-ubiquitylation circuitry that pro-
motes ATR activation and HR.
INTRODUCTION
Cells are constantly challenged by exogenous and endoge-
nous genotoxic stresses that threaten the integrity of their
genetic material. DNA replication stress causes the slowing
down and stalling of replication forks and is a particularly
pervasive source of genomic instability in cancer cells (1,2).
Replication stress was recently found to promote chromo-
somal instability in tumor cells and as such, may consti-
tute an important driver of genome evolution and adapta-
tion during oncogenesis (3). Extensive signaling pathways
collectively known as the DNA damage response (DDR)
detect a wide variety of DNA lesions including the aber-
rant replication fork structures generated during replication
stress and quickly reprogram the cellular epigenome, tran-
scriptome and proteome to activate cell-cycle checkpoints,
repair damaged portions of the genome, stabilize replication
forks and ultimately maintain genomic stability (4,5).
During replication stress, the uncoupling of DNA poly-
merases and replicative helicases at stalled forks produces
persistent regions of single-stranded DNA (ssDNA) in the
genome (6,7). This ssDNA is rapidly detected and bound
by the heterotrimeric ssDNA-binding complex Replica-
tion Protein A (RPA; RPA70, RPA32 and RPA14) form-
ing a crucial platform of the DDR: RPA-coated ssDNA
(RPA–ssDNA) (8,9). The accumulation of RPA–ssDNA
next to dsDNA junctions at blocked forks constitutes a
key signal for the recruitment and activation of a number
of replication-stress-response proteins including the master
checkpoint kinase ataxia telangiectasia-mutated (ATM)-
and Rad3-related kinase (ATR). The congregation of mul-
tiple factors at primer-template junctions present at stalled
forks activates ATRwhich phosphorylates downstream tar-
gets to turn on checkpoints, stabilize blocked forks and fa-
cilitate the accurate completion of genome replication (10–
13). Stalled forks are actively remodeled by helicases re-
cruited on the RPA–ssDNA platform to form regressed
structures that can use homologous recombination (HR)-
based mechanisms for immediate restart or which can
be nucleolytically processed to yield single-ended DNA
double-stranded breaks (DSBs) which may be repaired
through alternative recombination-based pathways such as
break-induced replication (14,15). In addition to its funda-
mental role in DDR signaling and replication fork protec-
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tion, RPA–ssDNA is also a central player during normal
DNA replication and in most repair pathways including
mismatch repair (MSH), nucleotide excision repair (NER)
and HR (16–18).
To regulate its many functions in genome maintenance,
the RPA–ssDNA platform is extensively modified dur-
ing the cell-cycle and in response to genotoxic agents
(8,19,20). For instance, RPA32 is phosphorylated by cyclin-
dependent kinases (CDKs) on serine residues 23 and 29
during S-phase (S23) and G2/M (S23 and S29) and this
has been shown to promote cell-cycle progression in human
cells (21–23). Moreover, phosphorylation of these CDK
sites is also enhanced by DNA damage which concomi-
tantly causes the N-terminus of RPA32 to undergo hyper-
phosphorylation at numerous additional serine and threo-
nine residues through the conjugated activity of the three
master phosphoinositide-3-kinase-related kinases (PIKKs)
of the DDR: ATR, ATM and DNAPK (24–30). Consti-
tutive hyper-phosphorylation of RPA32 has been shown
to impede the association of the RPA complex with ac-
tive replication centers (31). This led to the suggestion that
RPA32 phosphorylation by PIKKs reallocates its activity
from DNA replication to DNA damage signaling and re-
pair functions. Accordingly, phosphorylation of RPA has
been found to stimulate DNA repair and promote the pro-
tection and recovery of replication forks following geno-
toxic insults (22,26,29,32,33). Furthermore, there is evi-
dence that RPA phosphorylation stimulates checkpoint ac-
tivation andmaintenance (26,33). Finally, RPA32 phospho-
rylation and its subsequent dephosphorylation are impor-
tant for the regulation of the HR repair pathway (25,34,35).
More recently, an HR-promoting role for DNA damage-
induced SUMOylation of RPA70 has also been proposed
(19).
We and others have recently shown that DNA dam-
age inducesRPAubiquitylation (36–38). During replication
stress, the PRP19 E3 ubiquitin ligase, which normally func-
tions in RNA maturation, associates with RPA and stim-
ulates its ubiquitylation (39–41,37). Our data and that of
another research group established that PRP19 functions
as a ubiquitin ligase on the RPA–ssDNA platform to pro-
moteATR checkpoint activation and replication fork repair
(37,42). PRP19 also participates in HR but whether it func-
tions as a ubiquitin ligase on the RPA–ssDNA platform to
promote this repair pathway remains undisclosed (43). An-
other ubiquitin ligase, RFWD3 was also shown to promote
RPA complex ubiquitylation and to be required for replica-
tion fork restart and HR as well (38). How these two ubiq-
uitin ligases work together to promote the RPA-centered
DDR has not been addressed.
Here, we have investigated the regulation of RPA ubiq-
uitylation in response to damage. We report that whereas
RFWD3 is constitutively associated with the RPA complex,
PRP19 binds to the RPA complex after DNA damage. We
show that RPA32 phosphorylation stimulates both its in-
teraction with PRP19 and its ubiquitylation in response to
damage. Recruitment of PRP19 to sites of UV laser mi-
croirradiation also depends on RPA32 phosphorylation.
We identify a positively charged pocket in the PRP19WD40
repeat domain required for its interaction with RPA. Fi-
nally, we demonstrate that the damage-stimulated recogni-
tion of RPA by PRP19 and its ubiquitin ligase activity are
both required for optimal RPA ubiquitylation, checkpoint
activation and the repair of DSBs through HR. Our work
describes a novel phosphorylation–ubiquitylation cascade
occurring on RPA–ssDNA that drives ATR activation and
DNA repair through the HR pathway and thus provides a
greater molecular understanding of the role of RPA modi-
fication in genome maintenance.
MATERIALS AND METHODS
Cell culture
HeLa, HEK293T and U2OS DR-GFP cells were grown
in Dulbecco’s modified Eagle’s Medium (DMEM) supple-
mented with 10% fetal bovine serum and antibiotics.
Antibodies
The following antibodies were used in this study: PRP19
(ab27692, 1:400 IF, 1:1000 WB), ATM pS1981 (ab81292,
1:1000 WB), DNAPKcs pS2056 (ab18192, 1:1000 WB)
and RPA32 pT21 (ab109394, 1:5000 WB) antibodies were
from Abcam, CHK1 (SC-8404, 1:1000 WB), Myc (SC-
40, 1:1000 WB) and HA (SC-7392, 1:1000 WB) antibod-
ies were from Santa Cruz; RPA32 antibodies (MA1–26418,
1:500 IF, 1:1000 WB) were from Thermo, ATM (A300–
299A, 1:1000 WB), RPA32 pS4/8 (A300–245A, 1:1000
WB), RPA32 pS33 (A300–246A, 1:5000 WB), RFWD3
(A301–397A, 1:250 IF, 1:1000 WB) antibodies were from
Bethyl; ubiquitin antibodies were from Covance (MMS-
257P, 1:1000 WB); CDC5L antibodies were from BD-
Bioscience (612362, 1:1000 WB); anti-FLAG antibodies
were from Sigma (F1804, 1:800 IF, 1:1000 WB); CHK1
pS345 (2348, 1:1000 WB), GAPDH (5174, 1:1000 WB),
DNAPKcs (12311, 1:1000 WB) and tubulin (2144, 1:1000
WB) antibodies were from Cell Signaling.
Molecular cloning and cell line generation
The pDEST myc Ala10 RPA32 construct was obtained by
PCR amplification and BP cloning into a Gateway En-
try vector pDONR221 followed by LR recombination into
a pDEST myc Gateway Destination vector. The template
used for cloning was pET11d-RPA32 Ala10 (kind gift from
DrMarcWold,University of Iowa) which encodes aRPA32
construct inwhich the following residues aremutated to ala-
nines: S4, S8, S11, S12, S13, T21, S23, S29, S33 and S39.
For generating the stable HA-RPA32 WT and HA-RPA32
Ala10 cell lines, pDONR221 RPA32 WT or RPA32 Ala10
were LR recombined into a pHAGE EF1 3XHA-tag des-
tination vector. Viruses were prepared and infection and
selection of stable HeLa cell populations stably expressing
the RPA32 constructs were performed using puromycin as
a selection reagent. For the DR-GFP homologous recom-
bination assays and RPA ubiquitylation complementation
experiments, entry vectors containing WT, mPocket2, -
Ubox, Y405A and 3Xmut (C5A, V17E, Y33A (U-box de-
fective)) PRP19 constructs were recombined into a pHAGE
EF1 3XHA-tag Destination vector. Viruses were pro-
duced and infection was performed to isolate stable clones
of U2OS DR-GFP and HEK293T cells for the HR and
ubiquitylation assays respectively.
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RNA interference
The following siRNAs were used in this study. Ctl,
GGGUAUCGACGAUUACAAAdTdT, PRP19 #1, 5′-
GGGAUCUGGCGAAGCUU AAGAACUU-3′, PRP19
3′UTR, 5′-UGUAAGCAGUGAUCUAGUUUCAUUA-
3′, RFWD3, 5′-GGACCUACUUGCAAACUAUdTdT-3′
(44) and RPA32 3′UTR, 5′-AGUCAGAGGAGACAU
UUGAUAGAUG-3′ (Stealth siRNA from Thermo Fisher
Scientific/Life Technologies). Cells were transfected with
siRNAs using the Lipofectamine RNAimax reagent as per
manufacturer’s instructions (Life Technologies).
Protein complex purification
To capture SFB-tagged RFWD3 or PRP19 and its deriva-
tives, cells were lysed in NETN buffer (50 mM Tris–HCl
pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5% Igepal) con-
taining protease and phosphatase inhibitors and incubated
with streptavidin-coated magnetic beads (Life Technolo-
gies). Beads were retrieved with magnets and washed three
times with NETN buffer before the captured proteins were
eluted with SDS sample buffer.
Isolation of ubiquitylated proteins
Cells were transfected with pCDNA3.1 His6-ubiquitin
(kind gift from Dr Jianping Jin, University of Texas Medi-
cal School at Houston) or pCDNA4T/O Strep-HA ubiq-
uitin (kind gift from Dr Niels Mailand, University of
Copenhagen). Cells expressing His6-ubiquitin were lysed in
guanidium-HCl lysis buffer (6 M Guanidium HCl, 20 mM
Tris–HCl pH 8.0, 0.5 M NaCl, 5% glycerol, 25 mM Im-
idazole). Following sonication, Ni-NTA denaturing pull-
down was carried out directly in guanidium–HCl buffer us-
ing Ni-NTA agarose resin (Invitrogen). Precipitates were
washed twice in guanidium–HCl buffer containing 0.1%
Tween-20, twice in buffer B (guanidium–HCl buffer 1:4 in
buffer C) and twice in buffer C (25 mM Tris–HCl pH 6.8,
150 mM NaCl, 25 mM Imidazole, 10 mM NEM, 5% glyc-
erol, 0.1% Tween-20) before resuspension in Laemlli buffer.
Cells expressing Strep-HA-tagged ubiquitin were processed
as described previously (45). For the complementation ex-
periments, HEK293T cells were infected with lentiviruses
expressing HA-tagged PRP19 constructs. Populations of
cells expressing the various constructs were selected via
puromycin resistance carried by the lentiviral vector. Iso-
lated clones from these populations were used to carry out
the RPA ubiquitylation complementation experiments.
DR-GFP homologous recombination assays
U2OS DR-GFP cells (46) (a kind gift fromDrMaria Jasin,
Memorial Sloan Kettering Cancer Center) were transfected
with Ctl or PRP19-targeting siRNA and 24 h later plas-
mids expressing the I-Sce-I nuclease and mCherry were co-
transfected. Forty eight hours later, the efficiency of homol-
ogous recombination was evaluated as the % of mCherry-
positive cells that were also GFP positive using a BD FACS
Jazz Cell Sorter (BD Biosciences). For the complementa-
tion experiments, U2OS DR-GFP cells were infected with
lentiviruses expressing HA-tagged PRP19 constructs. Pop-
ulations of cells expressing the various constructs were se-
lected via puromycin resistance carried by the lentiviral vec-
tor. These cells were transfected with a 3′UTR targeting
PRP19 siRNA to monitor the capacity of the various mu-
tants to support HR.
UV-laser microirradiation
Cells were treated with 10 M BrdU 24 h prior to the mi-
croirradiation. Beforemicroirradiation, media was replaced
withDMEMwithout phenol red.Microirradiationwas per-
formed using a 355 nm UV laser on an Arcturus Veritas
Laser Capture Microscope (Life technologies) at the Ad-
vanced Tissue Resource Center of the Harvard NeuroDis-
covery Center or with a 355 nmUV laser onMMI Cell Cut
Plus Laser Capture microscope (MolecularMachines & In-
dustries AG) at the Universite´ de Sherbrooke.
Determination of the electrostatic potential of the PRP19
WD40 domain
The surface electrostatic potential of human PRP19 (pdb
4LG8) was generated using the PDB2PQR web server (47)
and the adaptive Poisson–Boltzmann solver (APBS) (48)
and were subsequently represented using PyMol (http://
www.pymol.org/).
RESULTS
PRP19 interacts with RPA and RFWD3 after DNA damage
In response to DNA damage, the RPA complex is poly-
ubiquitylated (36–38). We recently reported that depletion
of the PRP19 E3 ubiquitin ligase causes a substantial de-
crease in RPA32 ubiquitylation in response to DNA dam-
age (37). More recently, RFWD3, another E3 ubiquitin lig-
ase previously implicated in the elaboration of the RPA–
ssDNA-based DDR was also shown to stimulate damage-
induced RPA complex ubiquitylation in HeLa cells (38).
In agreement with a role for both of these ligases in this
process, we found that depletion of PRP19 or RFWD3
in HEK293T cells strongly impedes camptothecin (CPT)-
induced RPA70 ubiquitylation without significant changes
in ubiquitin expression levels (Figure 1A). These results sug-
gest that while both PRP19 and RFWD3 are required for
DNA damage-induced RPA ubiquitylation, neither ligase
is sufficient in vivo. Thus, the two E3 ligases must work in
concert in a DNA damage-induced manner.
The mechanism that triggers RPA ubiquitylation in re-
sponse to DNA damage remains unclear. The regulation
of the interactions between ubiquitin ligases and their
substrates is a prevalent control mechanism for stimulus-
induced ubiquitylation (49). Interestingly, although the
RFWD3–RPA interaction is constitutively found in un-
stressed cells and is not affected by DNA damage (Fig-
ure 1B and (44,50)), the interaction between the PRP19 E3
ubiquitin ligase andRPA is greatly stimulated byCPT treat-
ment (Figure 1C). Moreover, RFWD3 and PRP19 were
found as part of the same complex only upon DNA dam-
age induction and colocalized as punctate foci in UV laser
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Figure 1. PRP19 assembles with RFWD3 on RPA–ssDNA in response to DNA damage and promotes RPA ubiquitylation. (A) PRP19 and RFWD3
depletion perturb DNA damage-induced RPA ubiquitylation. Cells were transfected with siRNAs targeting either PRP19 or RFWD3 and a vector ex-
pressing His6-tagged ubiquitin, treated or not with CPT and lysed under denaturing conditions. Ni-NTA pulldown was performed to isolate ubiquitylated
proteins. (B) Cells were transfected with SFB- (S-protein, FLAG, streptavidin-binding peptide) GFP or SFB-RFWD3 vectors and streptavidin pulldown
of SFB-tagged proteins in untreated or CPT-treated cells was performed. The indicated proteins were immunoblotted. (C) Cells were transfected with SFB-
GFP or SFB-PRP19 vectors and streptavidin pulldown of SFB-tagged proteins isolated from untreated or CPT-treated cells was performed. The indicated
proteins were immunoblotted. (D) Cells were transfected with SFB-GFP or SFB-PRP19 and myc-RFWD3 vectors. Streptavidin pulldown of SFB-tagged
proteins isolated from untreated or CPT-treated cells was performed and the indicated proteins were immunoblotted. (E) HeLa cells transfected with an
SFB-PRP19 vector and pre-sensitized with BrdU were UV laser microirradiated. Immunofluorescence against endogenous  -H2AX, RFWD3 and FLAG
epitope was subsequently performed to monitor RFWD3 and PRP19 accrual at damage sites.
microirradiation stripes suggesting that they might func-
tion together to stimulate damage-induced ubiquitylation
by congregating on the RPA–ssDNA platform (Figure 1D
and E). These results also indicate that molecular events
must exist to trigger the RPA–PRP19 interaction and/or
the ability of RFWD3 to induce RPA ubiquitylation in re-
sponse to damage.
RPA hyper-phosphorylation correlates with increased
PRP19 binding and RPA ubiquitylation
Regulatory relationships between different PTMs such as
phosphorylation and ubiquitylation play an important part
in the precise control of signaling pathways (51). We thus
set out to investigate the relationship between phosphory-
lation and ubiquitylation of the RPA complex. The RPA70
andRPA32 subunits of theRPA complex are both ubiquity-
lated in response to CPT treatment (Figure 2A and Supple-
mentary Figure S1A) (37,38). Furthermore, RPA32 ubiq-
uitylation upon CPT treatment is also accompanied by a
strong induction in RPA32 hyper-phosphorylation. To fur-
ther investigate the genotoxic circumstances that might lead
to RPA complex ubiquitylation, we tested the ability of dif-
ferent DNA damaging agents to induce this modification
(Figure 2B and Supplementary Figure S1B). In agreement
with previous results, we found that CPT (1 M), ultravio-
let radiation (UV, 50 J/m2) and hydroxyurea (HU, 4 mM)
are potent inducers of RPA ubiquitylation, whereas ioniz-
ing radiation (IR, 10  ) did not induce this modification
(38). Interestingly, whereas CPT, UV and HU strongly in-
duce hyper-phosphorylation of RPA, IR is comparatively a
much weaker inducer of RPA32 N-terminal phosphoryla-
tion (Figure 2B). The correlation between RPA32 phospho-
rylation and ubiquitylation led us to examine the kinetics of
each modification.Whereas RPA32 hyper-phosphorylation
could be readily detected as soon as an hour after CPT
addition, the increase in mono and poly-ubiquitylation
of RPA32 and RPA70 could only be detected 2 h after
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Figure 2. RPA32 is phosphorylated and ubiquitylated in response to DNA damage that targets active replication forks. (A) Cells were transfected with a
vector expressing His6-tagged ubiquitin and lysed under denaturing conditions. Ni-NTA pulldown was performed to isolate ubiquitylated proteins. The
indicated proteins were detected with specific antibodies. (B) Cells were transfected with a vector expressing Strep-HA ubiquitin and treated with 1 or 5
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specific antibodies after Strep-Tactin pulldown. (E) A stable HEK293T cell line expressing SFB-PRP19 was treated with CPT 1 M for the indicated times.
SFB-PRP19 and its interactors were isolated using streptavidin-associated beads.
CPT treatment and kept increasing at subsequent time-
points (Figure 2C, Supplementary Figure S1C and data
not shown). To address whether ubiquitylated RPA was
also phosphorylated, we used site-specific antibodies to de-
tect phosphorylation of RPA32 at residues S4/8, S33 and
T21 in ubiquitylated proteins isolated from CPT-treated
cells. Whereas phosphorylation of RPA32 at each of the
sites could be detected after 1 h, ubiquitylated phospho-
RPA32 started increasing after 2 h of treatment indicat-
ing that at least some species of RPA32 are phosphorylated
and ubiquitylated at the same time (Figure 2D). Interest-
ingly, the damage-induced interaction of PRP19 with RPA
is also detected after 2 h of CPT treatment, which corre-
lates with the kinetics of RPA ubiquitylation (Figure 2E).
Moreover, we found that PRP19 exhibits a strong prefer-
ence for the hyper-phosphorylated form of RPA suggest-
ing that this modification might help tether PRP19 to the
RPA–ssDNA platform (compare P-RPA32/RPA32 ratios
in input and PRP19 pulldown in Figure 2E). Collectively,
these results show that RPA hyper-phosphorylation corre-
lates with increased PRP19 binding and RPA ubiquityla-
tion.
PIKKs promote RPA hyper-phosphorylation, PRP19 binding
and RPA ubiquitylation
Because the RPA32 N-terminus is targeted by the PIKKs
ATM,ATR andDNA-PK in response to damage, we exam-
ined the importance of each of these kinases for RPA phos-
phorylation and ubiquitylation using specific inhibitors
(26,27,52,53). As shown in Figure 3A and Supplementary
Figure S2A, inhibition of a single kinase led to weak de-
creases in RPA32 and RPA70 ubiquitylation with the most
pronounced decrease observed with the single ATR inhibi-
tion. It is worth noting that to robustly detect RPA ubiq-
uitylation, 4 h of CPT treatment were necessary. This pro-
longed treatment results in only a weak inhibition of RPA
hyper-phosphorylation levels when ATM, ATR or DNA-
PK inhibitors are used individually (Figure 3A). However,
even after 4 h of CPT treatment, inhibition of all three ki-
nases at the same time completely abrogated both damage-
stimulated RPA phosphorylation and ubiquitylation. Sup-
plementary Figure S2B shows the effective inhibition of
each kinase when using VE-821, KU55933 and NU7026 to
inhibit ATR, ATM and DNA-PK respectively. Concomi-
tantly, whereas the inhibition of individual kinases par-
tially inhibited the damage-induced PRP19-RPA interac-
tion, inhibition of all three kinases at the same time com-
pletely abrogated the formation of this complex after dam-
age (Figure 3B). In agreement with the partial impairment
8864 Nucleic Acids Research, 2017, Vol. 45, No. 15
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MCPT for 4 h and lysed under denaturing conditions. Strep-Tactin pulldown was performed to isolate ubiquitylated proteins. (B) Cell transfection with
an SFB-PRP19 vector were treated as in A and streptavidin pulldown was performed to isolate PRP19 along with its interactors. Controls for the efficiency
of the inhibitor treatments are provided in (S2A). (C and D) U2OS cells were pre-sensitized with 10 MBrdU, treated with the indicated inhibitors along
with DRB for 1 h and damaged by UV-laser microirradiation. Recruitment of PRP19 and RPA32 was monitored 2 h after damage by immunofluorescence.
of the PRP19-RPA interaction, inhibition of single kinases
slightly reduced the recruitment of PRP19 to RPA-labeled
sites of UV-laser microirradiation (Figure 3C andD). Strik-
ingly, inhibition of all 3 kinases led to a complete abrogation
of PRP19 accumulation at laser stripes. Instead of being ac-
tively recruited, PRP19 was excluded and formed an anti-
stripe at the site of UV-laser damage when microirradiation
was performed in the presence of ATM, ATR and DNA-
PK inhibitors (White arrow, Figure 3C bottom panel). Such
anti-stripes are reminiscent of the behavior of other RNA
processing proteins at sites of UV damage and might be at-
tributable to the downregulation of transcription at sites of
DNA damage (54–57). Therefore, PRP19 is likely released
from transcription sites in the damaged areas, and subse-
quently recruited to damage sites by phospho-RPA.
RPA32 phosphorylation is required for PRP19 binding and
RPA ubiquitylation
PIKKs phosphorylate multiple substrates uponDNAdam-
age (55,58,59). To ascertain whether RPA phosphorylation
might specifically promote its interaction with PRP19 and
its ubiquitylation, we tested whether a form of RPA32 lack-
ing multiple phosphorylation sites (S4, S8, S11–13, T21,
S23, S29, S33, T39) at its N-terminus could interact with
PRP19 in response to DNA damage. This mutant was se-
lected because it cannot be phosphorylated upon DNA
damage but is still able to bind ssDNAand destabilizeDNA
helixes as well as the WT version in vitro (60).
We first engineered cell lines expressing WT or Ala10
RPA32 mutants at a level similar to endogenous RPA32
and tested whether impairment of RPA32 phosphorylation
might impact its interaction with PRP19. Upon CPT treat-
ment, WT RPA32 interacted strongly with PRP19 upon
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DNA damage, but the Ala10 mutant, although expressed
similarly as WT and able to relocate to sites of DNA dam-
age (Figure 4B and C), was unable to productively inter-
act with PRP19 upon CPT treatment (Figure 4A). Con-
trastingly, RFWD3 interacted equally well in the presence
or absence of DNA damage with both WT and the Ala10
mutant, indicating that the phosphorylation status of the
RPA32 N-terminus has no effect on its constitutive interac-
tion with RFWD3 (Supplementary Figure S3).
To further examine the importance ofRPA32 phosphory-
lation for PRP19 relocalization toRPA–ssDNAuponDNA
damage, we knocked-down endogenous RPA32 in cell lines
expressing HA-tagged WT or Ala10 RPA32 mutants us-
ing a 3′UTR-targeted siRNA (Figure 4B). As previously
described, knockdown of endogenous RPA32 destabilized
RPA70 (Figure 4B, first 2 lanes). Expression of HA-tagged
WT or Ala10 RPA32 rescued RPA70 levels indicating that
both of these constructs form stable RPA complexes. Next,
we monitored the recruitment of PRP19 at UV-laser stripes
in cell lines where endogenous RPA32 was replaced by WT
or Ala10 RPA32. As shown in Figure 4C, RPA32 knock-
down in non-complemented cells dramatically decreased
the recruitment of PRP19 to sites of DNA damage. In fact,
instead of PRP19 recruitment, anti-stripes of PRP19 could
be observed at most RPA32 positive stripes (Figure 4C, up-
per panels and D). Of note, the intensity of RPA32 stripes
in non-complemented cells was much weaker than in con-
trol siRNA-treated cells indicating an efficient knockdown
of endogenous RPA32. In cells carrying WT RPA32-HA,
the level of PRP19 recruitment remained very high despite
the knockdown of endogenous RPA32 (Figure 4C, middle
panels and D). However, in cells expressing only the Ala10
mutant, the recruitment of PRP19 was strongly decreased.
Moreover, anti-stripes were present in most RPA32 posi-
tive stripes (Figure 4C, lower panel, D). These data strongly
suggest that PRP19 recruitment ontoRPA–ssDNA requires
RPA32 hyper-phosphorylation.
Finally, we tested whether RPA phosphorylation pro-
motes its ubiquitylation. As shown in Figure 4E, whereas
the ubiquitylation of WT RPA32 was greatly induced by
CPT treatment, the ubiquitylation of Ala10 RPA32 was un-
responsive to DNA damage. Because the Ala10 mutant still
interacts constitutively with RFWD3 but cannot be ubiqui-
tylated efficiently, our data suggests that the RFWD3–RPA
interaction is not sufficient for maximal damage-induced
RPA ubiquitylation. It is plausible that PIKK-mediated
RPA hyper-phosphorylation promotes its interaction with
PRP19, which may function in concert with RFWD3 to in-
duceRPAubiquitylation during replication stress. In a non-
mutually exclusive scenario, hyper-phosphorylation ofRPA
may render RPA a better substrate for RFWD3 and/or
PRP19, contributing to the damage-induced RPA ubiqui-
tylation.
A positively charged surface on the PRP19WD40 repeat do-
main mediates its damage-induced interaction with RPA
Because RPA phosphorylation is required for its interac-
tion with PRP19 at sites of damage, we looked for pos-
itively charged surfaces on the WD40 repeat domain of
PRP19, which is essential for its interaction with RPA (37).
We reasoned that these electropositive patches might me-
diate PRP19 damage-induced interaction with the phos-
phorylated RPA complex. Using the available crystallo-
graphic structure of human PRP19 WD40 repeat domain
(Structural Genomics Consortium, PDB:4LG8), we were
able to identify two surface accessible basic pockets on the
WD40 surface that may potentially accommodate nega-
tively charged peptides (Figure 5A and B).Wemutated pos-
itively charged lysine and arginine residues in each pocket
to alanines in order to decrease their electrostatic potential
and evaluated the ability of these mutants to interact with
RPA in a damage-inducible manner. Although mPocket1
(K244AK265AK266A) still interacted with the RPA com-
plex as well as WT, mutating two residues in Pocket 2 com-
pletely abolished the ability of PRP19 to interact with the
RPA complex in response to damage (Figure 5C). Alto-
gether, these data imply that following RPA32 phosphory-
lation, PRP19 is recruited to damaged replication forks via
a basic pocket in its WD40 domain where it may cooper-
ate with RFWD3 to ubiquitylate RPA and regulate damage
signaling and repair.
The RPA-binding surface and ubiquitin ligase activity of
PRP19 are required for damage-induced RPA ubiquitylation
We next addressed the roles of the PRP19 RPA binding
pocket and its U-box E3 ubiquitin ligase domain for RPA
ubiquitylation. First, we monitored the impact of PRP19
depletion using a 3′UTR-targeted siRNA on RPA32 and
RPA70 ubiquitylation upon DNA damage. As seen in Fig-
ure 6A and similarly to another PRP19-targeting siRNA
(Figure 1A), PRP19 depletion strongly abrogated both
RPA32 and RPA70 ubiquitylation upon CPT treatment.
We could also see a similar decrease of HU-induced RPA
ubiquitylation following PRP19 depletion (Supplementary
Figure S4A). Next, we obtained stable cell lines expressing
siRNA-resistant HA-tagged WT and mutant PRP19. Us-
ing the WT PRP19 cell line, we could rescue RPA32 and
RPA70 CPT-induced ubiquitylation, thereby demonstrat-
ing that PRP19 is necessary for RPA ubiquitylation. We
further tested whether the ability of PRP19 to interact with
RPA and its ubiquitin ligase activity of PRP19 are required
for RPA ubiquitylation. Using stable cell lines expressing
mPocket2 PRP19 or a PRP19 completely lacking its U-box
E3 ubiquitin ligase domain (U-box), we determined that
both of these PRP19 mutants were unable to support opti-
mal RPA complex damage-induced ubiquitylation (Figure
6B). Thus, our data clearly demonstrate that both the ubiq-
uitin ligase activity of PRP19 and its damage-inducible in-
teraction with RPA are required for optimal RPA complex
ubiquitylation during replication stress.
PRP19 functions as an E3 ubiquitin ligase on RPA–ssDNA
to promote HR
RFWD3 and PRP19 were both shown previously to pro-
mote DSB repair through HR but whether PRP19 func-
tions as a ubiquitin ligase on RPA–ssDNA to promote this
DSB repair pathway has not been thoroughly addressed
(38,43,61). To monitor HR by gene conversion, we used
the well-established DR-GFP system to determine whether
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Figure 4. DNA-damage-induced RPA phosphorylation promotes its ubiquitylation. (A) HeLa cell lines stably expressing HA-taggedWT or Ala10 RPA32
mutants were transfected with a vector expressing SFB-PRP19. Cells were then treated with CPT 1 M for 4 h, lysed and SFB-PRP19 and its interactors
were isolated using streptavidin-associated beads. (B) Stable HeLa cell lines expressing the indicated HA-tagged RPA32 constructs were transfected with
an siRNA targeting the 3′ untranslated region for the RPA32 mRNA. 72 h later, cells were treated with 1 MCPT for 2 h, lysed and the indicated proteins
were detected using specific antibodies. (C) Alternatively, cells transfected as in (B) were microirradiated and processed for immunofluorescence to examine
PRP19 recruitment to laser stripes. (D) Histogram representing the recruitment of endogenous PRP19 to RPA32 stripes after laser microirradiation. The
error bars correspond to biological triplicate experiments. At least 100 microirradiated cells were examined for each replicate. (E) Cells were transfected
with vectors expressing His6-tagged ubiquitin and myc-tagged WT or Ala10 RPA32 mutants and treated with 1 M CPT for 3 h. Ubiquitylated proteins
were isolated by denaturing Ni-NTA pulldown.
depletion of PRP19 with two independent siRNAs would
impede this repair pathway (46). In agreement with previ-
ous results, we observed a 60–70% decrease in gene con-
version efficiency upon PRP19 depletion. Next, we per-
formed complementation experiments using a stable cell
line expressing an HA-tagged WT PRP19 at near endoge-
nous levels. In this cell line, we used the PRP19 3′UTR-
targeting siRNA to specifically deplete endogenous PRP19
and were able to partially but reproducibly rescue the HR
defect (Supplementary Figure S4B). One possible explana-
tion for this incomplete rescue may reside in the fact that
N-terminal tagging of PRP19 with HA epitopes might per-
turb its ability to ubiquitylate substrates as the tag is adja-
cent to its U-box. In agreement with this, RPA ubiquityla-
tion is also partially rescued by WT PRP19 (Figure 6B). In
addition, we further tested whether the ability to interact
with RPA and the ubiquitin ligase activity of PRP19 are re-
quired for its function inHR.Using stable cell lines express-
ing mPocket2 PRP19 mutant or PRP19 completely lacking
its U-box E3 ligase domain (U-box), we were unable to
rescue the HR defect. Moreover, the Y405A PRP19 mutant
which we have previously shown is unable to productively
interact with RPA upon damage and a triple point mutant
(3Xmut, C5A/V17E/Y33A) in conserved residues of theU-
box domain of PRP19 were also unable to significantly res-
cue the HR defect caused by PRP19 depletion (Supplemen-
tary Figure S4C) (62,63). Of note, both the 3Xmut construct
and the mPocket2 mutants were defective for ATR activa-
tion in response to CPT (Supplementary Figure S4D,E).
Altogether, these data strongly argue that PRP19 must be
recruited by RPA–ssDNA and function as an E3 ligase to
promote full ATR activation and the HR repair pathway.
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Figure 5. The PRP19 WD40 domain contains an electropositive surface that mediates its damage-induced interaction with the RPA complex. (A and B)
Electrostatic surface potential of the WD40 repeats domain of human PRP19 identifies two major electropositive surfaces (blue). The mutated positively
charged residues in the mPocket1 and mPocket2 PRP19 constructs are shown in magenta. (C) Cells were transfected with WT SFB-PRP19 or the indi-
cated mutants and treated with 1 M CPT 24 h later. SFB-PRP19 constructs and their interactors were isolated using streptavidin-associated beads and
immunoblotted with the indicated antibodies.
DISCUSSION
A phosphorylation-ubiquitylation cascade on the RPA–
ssDNA platform
The DDR is regulated by a complex array of PTMs which
modify existing proteins to reorient their activities towards
genome maintenance at the sites of DNA damage (64,65).
These PTMs occur on two main nucleoprotein structures
that orchestrate the DDR: chromatin and RPA–ssDNA.
Several seminal papers published in the last few years have
elegantly shown that on the chromatin flanking DSBs,
phosphorylation of the histone variant H2A.X triggers a
series of events leading to the recruitment of the RNF8 and
RNF168 ubiquitin ligases which work together to regulate
repair pathway choice at DSBs (64,66).
We now show that a similar phosphorylation–
ubiquitylation PTM cascade occurs on RPA–ssDNA
to promote ATR signaling and HR. Our work supports a
working model whereby RPA phosphorylation through the
combined efforts of ATM, ATR and DNA-PK promotes
the recruitment of PRP19 which works together with
RFWD3 to ubiquitylate RPA and potentially additional
substrates (Supplementary Figure S6). Prior to DNA dam-
age, RFWD3 is associated with RPA32 but our data show
that it cannot efficiently polyubiquitylate the RPA com-
plex without (1) RPA32 phosphorylation and (2) PRP19
tethering to RPA–ssDNA. Additionally, phosphorylation
of RFWD3 by ATM and ATR may stimulate its ubiquitin
ligase activity (67). The requirement of these conditions
for optimal RPA ubiquitylation may limit the extent of
this modification to prevent erroneous ATR activation
and engagement of the HR pathway during normal DNA
replication.
How might PRP19 and RFWD3 work together to pro-
mote full RPA ubiquitylation? RFWD3 depletion does not
appear to affect the recruitment of PRP19 on RPA–ssDNA
produced by UV laser microirradiation (Supplementary
Figure S5A and B). Conversely, depletion of PRP19 or
RFWD3 did not significantly impact each other’s cellu-
lar levels (Supplementary Figure S5B–D). Interestingly,
RFWD3 has been shown to collaborate with the MDM2
ubiquitin ligase to promote p53 ubiquitylation (68). In that
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Figure 6. The PRP19 E3 ubiquitin ligase activity and its electropositive RPA-binding pocket are required for RPA ubiquitylation and homologous re-
combination. (A) Cells were transfected with Ctl or PRP19 3′UTR-targeted siRNA and 24 h later with a vector expressing Strep-HA ubiquitin. Twenty
four hours later, cells were treated with 1 M CPT for 3 h and lysed under denaturing conditions. Strep-Tactin pulldown was performed to isolate ubiq-
uitylated proteins. (B) Cells expressing the indicated HA-PRP19 contructs were transfected with Ctl or PRP19 3′UTR-targeted siRNA and a Strep-HA
ubiquitin vector and exposed to CPT as in A. Ubiquitylated proteins were isolated and the indicated proteins were detected by immunoblotting. (C) U2OS
DR-GFP cells were transfected with the indicated siRNAs and subsequently co-transfected with mCherry and I-Sce-I expressing plasmids. Homologous
recombination efficiency is measured as the % of GFP- and mCherry-positive cells to normalize for transfection efficiency and HR efficiency is plotted
relatively to Ctl siRNA transfected cells. The graph represents the mean obtained from three independent experiments (***P < 0.001, Student’s t-test).
(D) U2OS DR-GFP cells stably expressing the indicated HA-PRP19 constructs were transfected with Ctl or PRP19 3′UTR siRNAs and subsequently
co-transfected with mCherry and I-Sce-I expressing plasmids. The graphs represents the % HR in PRP19 3′UTR siRNA-transfected cells relative to Ctl
siRNA-transfected cells for each cell line and were compiled from three independent experiments (**P < 0.01, ns = non-significant, Student’s t-test).
context, RFWD3 alone is unable to ubiquitylate p53 but
when combined with MDM2, it strongly enhances p53
ubiquitylation. It is plausible that a similar collaboration
between RFWD3 and PRP19 supports optimal RPA ubiq-
uitylation. It is also possible that RFWD3 and PRP19
might target different lysine residues on the RPA subunits
which when combined allow robust ubiquitylation of the
complex. Further work will be required to sort out these hy-
potheses. In yeast, there is no obvious ortholog of RFWD3,
Prp19 however is highly conserved and is also known as
Pso4 for PSOralen sensitive 4 as it was identified in a genetic
screen for sensitivity to this crosslinking agent. Similarly to
PRP19, Prp19/Pso4 functions in interstrand crosslink re-
pair and mitotic recombination (69,70). It will be interest-
ing to determine whether Prp19/Pso4 also associates with
and ubiquitylates yeast RPA in response to damage.
Interestingly, both RFWD3 and PRP19 also promote
RPA phosphorylation (37,38,50). Mutation of specific
RPA32 ubiquitylation sites or impairment of its associa-
tion with RFWD3 also dampenRPA phosphorylation (38).
These prior data along with the evidence provided here that
RPA phosphorylation tethers PRP19, which together with
RFWD3 stimulates RPA ubiquitylation, cement the exis-
tence of a feed-forward loop on RPA–ssDNA. Similarly
to the propagation of phosphorylation and ubiquitylation
across chromatin adjacent toDSBs by the  -H2AX-RNF8-
RNF168DDRaxis, the ability of both PRP19 andRFWD3
to promote RPA phosphorylation and ubiquitylation may
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support the simultaneous spreading of these modifications
to extensive stretches of RPA–ssDNA at stalled replication
forks or upon resection of DSB to ensure robust damage
signaling and repair via HR (37,38,42).
PRP19 promotes RPA phosphorylation via ATR activa-
tion by acting as a ubiquitin ligase on RPA–ssDNA (Sup-
plementary Figure S4D,E and (37,42,71)). More specifi-
cally, PRP19 promotes phosphorylation of RPA32 S33 by
ATR which further stimulates RPA hyper-phosphorylation
at additional sites by ATM and DNA-PK kinases (22,29).
We showed previously that the ATR-ATRIP complex has
affinity for K63-linked ubiquitin chains and that ATR-
ATRIP recruitment to damage sites is decreased upon
PRP19 downregulation. K63-linked chains along with
other forms of non-degradative ubiquitin moieties are con-
jugated to the RPA complex suggesting that RPA ubiqui-
tylation could promote its phosphorylation by enhancing
ATR activation and perhaps the accessibility of phospho-
rylation sites to PIKKs (38). Concomitantly, phosphory-
lated RPA might also be a better substrate for ubiquityla-
tion, which would also enhance the robustness of the feed-
forward loop. The PRP19-XAB2 complex was also recently
shown to regulate DSB resection (61). It is possible that
some of the decrease in ATR activation and RPA ubiquity-
lation caused by PRP19 depletion is due to a defect in DSB
resection. However, since PRP19 can ubiquitylate RPA di-
rectly in vitro and because PRP19 complex depletion also
decreases RPA ubiquitylation and phosphorylation in re-
sponse to short HU treatment which does not cause DSBs
and resection (Supplementary Figure S4A and (71)), we
favour the possibility that PRP19 acts directly on the RPA
complex to promote its ubiquitylation and phosphorylation
via ATR activation (37).
In the case of RFWD3, while its depletion can impede
both CHK1 and RPA32 phosphorylation in certain cell
types, the decrease in CHK1 phosphorylation appears to be
more context-specific than for PRP19 (38,44,50). As such
it is worth noting that proteins such as NBS1 and the re-
cently described ATR activator ETAA1 may promote the
phosphorylation of RPA32 by ATR but are not critically
important for CHK1-targeting which is more sensitive to
TOPBP1 depletion (72–75). It is possible that RFWD3 and
PRP19 participate in ATR activation under complemen-
tary circumstances with PRP19 functioning both at the
double-stranded/single-stranded DNA junction to medi-
ate ATR activation and CHK1 phosphorylation and on
RPA–ssDNA to promote RPA phosphorylation. Notably,
a direct interaction between the CDC5L component of the
PRP19 complex and ATRwas shown to promote canonical
ATR signaling through CHK1 phosphorylation and might
contribute to the observed differences between PRP19 and
RFWD3 depletion on ATR activity (71). Constrastingly,
RFWD3 would function mostly on RPA–ssDNA itself,
hence the greater impact of its depletion on RPA phospho-
rylation.
Our data clearly shows that PRP19 preferentially inter-
acts with the hyper-phosphorylated form of the RPA com-
plex and that damage-induced RPA phosphorylation is re-
quired for its ubiquitylation and interaction with PRP19
in vivo. There are a number of ways through which RPA
phosphorylation might trigger its interaction with PRP19.
One possibility is that PRP19might directly recognize phos-
phorylated RPA itself similar to the recently described en-
hanced interaction between PALB2 and phosphorylated
RPA in vitro (32). However, we were unable to detect a
direct interaction between the WD40 repeat domain of
PRP19 and RPA32 N-terminus phosphopeptides (data not
shown) suggesting that while phosphorylation of RPA pro-
motes the PRP19-RPA interaction in vivo, it is not suf-
ficient to recapitulate the full PRP19-RPA interaction in
vitro. This is in agreement with the fact that mutation of the
RPA70 N-terminus also impedes the RPA-PRP19 interac-
tion (37). The BCAS2 subunit of the core PRP19 complex
may also contact RPA directly, again suggesting a multi-
pronged PRP19-RPA interaction in vivo (42). Alternatively,
RPAphosphorylationmay promote the removal of proteins
that might compete with PRP19 for RPA binding. For in-
stance, RPA phosphorylation impairs its interaction with
the MRN complex (76).
RPA ubiquitylation and HR
Both PRP19 and RFWD3 promote DNA repair through
HR (Figure 6C and D and Supplementary Figure S4B and
C and (38,43)). A previous paper concluded that PRP19
itself but not its ubiquitin ligase activity are required for
HR. However, the mutant used to complement the HR de-
fect in this previous report contained a small 3 amino acid
deletion V17, S18, P19 in the middle of the UBOX domain
(62,63). Because no data was presented to demonstrate the
non-functionality of this mutant it is possible that it still has
sufficient ubiquitin ligase activity to support HR. Here, we
provide 2 additional PRP19 ubiquitin ligase-deficient mu-
tants; one in which the complete U-box domain has been
removed (U-box) making it impossible for PRP19 to re-
cruit E2 partners and another (3Xmut) in whichwemutated
three highly conserved residues equivalent to functionally
important amino acids in Saccharomyces cerevisiae Prp19
C5A (C3), V17E (L15) and Y33A (Y31). Each of these mu-
tations is unable to rescue the viability defect of the Prp19
mutant yeasts indicating that the ubiquitin ligase activity is
obliterated in individual mutants (62,63).We also show that
two independent RPA interaction point mutants of PRP19
are unable to support efficient HR. Thus, our data strongly
supports a model in which the PRP19 ubiquitin ligase ac-
tivity on RPA–ssDNA is important for HR and ATR acti-
vation in mammalian cells.
At this point, it remains to be determined how PRP19
and RFWD3-mediated ubiquitylation on the RPA–ssDNA
platform promotes HR. Indeed, the presence of PRP19 and
RFWD3 on the RPA–ssDNA platform puts them in the
vicinity of multiple genome maintenance factors that could
become ubiquitylation substrates during the DDR (8). Re-
cently, RFWD3was shown participate in the ubiquitylation
of both RPA and RAD51 in response to mitomycin C treat-
ments (67). Additionally, a mutation in a Fanconi anemia
patient that impairs the interaction of RFWD3 with RPA
interferes with RPA and RAD51 ubiquitylation. Ubiqui-
tylation of RPA and RAD51 appears to promote their
clearance from interstrand crosslinking damage sites which
paves the way for latter steps in the HR pathway (67,77).
Interestingly, PRP19 depletion also increases the retention
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time of RAD51 foci during HU-induced replication stress
(37). It will be interesting to determine whether PRP19 and
RFWD3 have overlapping as well as unique ubiquitylation
targets on RPA–ssDNA and determine how this plays into
DDR activation and DNA repair by HR.
In conclusion, our work shows for the first time that RPA
phosphorylation acts to bring together the RFWD3 and
PRP19 ubiquitin ligases on RPA–ssDNA, which promote
ATR activation and HR. We provide a mechanism that ex-
plains the DNA damage regulation of RPA ubiquitylation
and show that DNA damage signals propagate on both
the chromatin and RPA–ssDNA platforms through simi-
lar phosphorylation and ubiquitylation-based feed-forward
loops, highlighting fundamental organizational principles
of the DDR.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We would like to thank Dr Marc Wold, Dr Xiaohua Wu,
Dr Niels Mailand, Dr Jianping Jin, Dr Caroline Saucier,
Dr Andrew E.H. Elia, Dr Stephen J. Elledge and Dr Maria
Jasin for the generous gift of reagents. We thank Dr Hai
Dang Nguyen for reagent characterization. We also want
to thankDaniel Garneau andDominique Jean for technical
support during the microscopy and FACS experiments.
FUNDING
Discovery Grant from the Natural Sciences and Engineer-
ing Research Council of Canada [Discovery grant 5026 to
A.M]; Next-Generation of Scientists Scholarship from the
Cancer Research Society [21531 to A.M]; Project Grant
from the Canadian Institutes of Health [Project Grant
376288 to A.M.]; National Institutes of Health [GM076388
and CA197779 to L.Z]. Funding for open access charge:
Next-Generation of Scientists Scholarship; NIH Grant.
Conflict of interest statement.None declared.
REFERENCES
1. Macheret,M. and Halazonetis,T.D. (2015) DNA replication stress as
a hallmark of cancer. Annu. Rev. Pathol. Mech. Dis., 10, 425–448.
2. Zeman,M.K. and Cimprich,K. (2013) Causes and consequences of
replication stress. Nat. Cell Biol., 16, 2–9.
3. Burrell,R.A., McClelland,S.E., Endesfelder,D., Groth,P.,
Weller,M.-C., Shaikh,N., Domingo,E., Kanu,N., Dewhurst,S.M.,
Gronroos,E. et al. (2013) Replication stress links structural and
numerical cancer chromosomal instability. Nature, 494, 492–496.
4. Ciccia,A. and Elledge,S.J. (2010) The DNA damage response: making
it safe to play with knives.Mol. Cell, 40, 179–204.
5. Hoeijmakers,J.H.J. (2001) Genome maintenance mechanisms for
preventing cancer. Nature, 411, 366–374.
6. Byun,T.S., Pacek,M., Yee,M., Walter,J.C. and Cimprich,K.A. (2005)
Functional uncoupling of MCM helicase and DNA polymerase
activities activates the ATR-dependent checkpoint. Genes Dev., 19,
1040–1052.
7. Pacek,M. and Walter,J.C. (2004) A requirement for MCM7 and
Cdc45 in chromosome unwinding during eukaryotic DNA
replication. EMBO J., 23, 3667–3676.
8. Mare´chal,A. and Zou,L. (2015) RPA-coated single-stranded DNA as
a platform for post-translational modifications in the DNA damage
response. Cell Res., 25, 9–23.
9. Wold,M.S. (1997) Replication protein A: a heterotrimeric,
single-stranded DNA-binding protein required for eukaryotic DNA
metabolism. Annu. Rev. Biochem., 66, 61–92.
10. Zou,L. and Elledge,S.J. (2003) Sensing DNA damage through ATRIP
recognition of RPA–ssDNA complexes. Science, 300, 1542–1548.
11. Cimprich,K.A. and Cortez,D. (2008) ATR: an essential regulator of
genome integrity. Nat. Rev. Mol. Cell Biol., 9, 616–627.
12. Mare´chal,A. and Zou,L. (2013) DNA damage sensing by the ATM
and ATR kinases. Cold Spring Harb. Perspect. Biol., 5, 1–17.
13. Nam,E.A. and Cortez,D. (2011) ATR signalling: more than meeting
at the fork. Biochem. J., 436, 527–536.
14. Petermann,E., Orta,M.L., Issaeva,N., Schultz,N. and Helleday,T.
(2010) Hydroxyurea-stalled replication forks become progressively
inactivated and require two different RAD51-mediated pathways for
restart and repair.Mol. Cell, 37, 492–502.
15. Petermann,E. and Helleday,T. (2010) Pathways of mammalian
replication fork restart. Nat. Rev. Mol. Cell Biol., 11, 683–687.
16. Symington,L.S. and Gautier,J. (2011) Double-strand break end
resection and repair pathway choice. Annu. Rev. Genet., 45, 247–271.
17. Marteijn,J.A., Lans,H., Vermeulen,W. and Hoeijmakers,J.H.J. (2014)
Understanding nucleotide excision repair and its roles in cancer and
ageing. Nat. Rev. Mol. Cell. Biol., 15, 465–481.
18. Kunkel,T.A. and Erie,D.A. (2005) DNA mismatch repair. Annu. Rev.
Biochem., 74, 681–710.
19. Dou,H., Huang,C., Singh,M., Carpenter,P.B. and Yeh,E.T.H. (2010)
Regulation of DNA Repair through DeSUMOylation and
SUMOylation of replication protein A complex.Mol. Cell, 39,
333–345.
20. Binz,S.K., Sheehan,A.M. and Wold,M.S. (2004) Replication protein
A phosphorylation and the cellular response to DNA damage. DNA
Repair (Amst.), 3, 1015–1024.
21. Din,S., Brill,S.J., Fairman,M.P. and Stillman,B. (1990)
Cell-cycle-regulated phosphorylation of DNA replication factor A
from human and yeast cells. Genes Dev., 4, 968–977.
22. Anantha,R.W., Vassin,V.M. and Borowiec,J.A. (2007) Sequential and
synergistic modification of human RPA stimulates chromosomal
DNA repair. J. Biol. Chem., 282, 35910–35923.
23. Stephan,H., Concannon,C., Kremmer,E., Carty,M.P. and
Nasheuer,H.-P. (2009) Ionizing radiation-dependent and independent
phosphorylation of the 32-kDa subunit of replication protein A
during mitosis. Nucleic Acids Res., 37, 6028–6041.
24. Shiotani,B., Nguyen,H.D., Ha˚kansson,P., Mare´chal,A., Tse,A.,
Tahara,H. and Zou,L. (2013) Two distinct modes of ATR activation
orchestrated by Rad17 and Nbs1. Cell Rep., 3, 1651–1662.
25. Liaw,H., Lee,D. and Myung,K. (2011) DNA-PK-dependent RPA2
hyperphosphorylation facilitates DNA repair and suppresses sister
chromatid exchange. PLoS One, 6, e21424.
26. Liu,S., Opiyo,S.O., Manthey,K., Glanzer,J.G., Ashley,A.K.,
Amerin,C., Troksa,K., Shrivastav,M., Nickoloff,J.A. and
Oakley,G.G. (2012) Distinct roles for DNA-PK, ATM and ATR in
RPA phosphorylation and checkpoint activation in response to
replication stress. Nucleic Acids Res., 40, 10780–10794.
27. Block,W.D., Yu,Y. and Lees-Miller,S.P. (2004) Phosphatidyl inositol
3-kinase-like serine/threonine protein kinases (PIKKs) are required
for DNA damage-induced phosphorylation of the 32 kDA subunit of
replication protein A at threonine 21. Nucleic Acids Res., 32,
997–1005.
28. Olson,E., Nievera,C.J., Klimovich,V., Fanning,E. and Wu,X. (2006)
RPA2 is a direct downstream target for ATR to regulate the S-phase
checkpoint. J. Biol. Chem., 281, 39517–39533.
29. Vassin,V.M., Anantha,R.W., Sokolova,E., Kanner,S. and
Borowiec,J.A. (2009) Human RPA phosphorylation by ATR
stimulates DNA synthesis and prevents ssDNA accumulation during
DNA-replication stress. J. Cell Sci., 122, 4070–4080.
30. Zernik-Kobak,M., Vasunia,K., Connelly,M., Anderson,C.W. and
Dixon,K. (1997) Sites of UV-induced phosphorylation of the p34
subunit of replication protein A from HeLa cells. J. Biol. Chem., 272,
23896–23904.
31. Vassin,V.M., Wold,M.S. and Borowiec,J.A. (2004) Replication protein
A (RPA) phosphorylation prevents RPA association with replication
centers.Mol. Cell. Biol., 24, 1930–1943.
32. Murphy,A.K., Fitzgerald,M., Ro,T., Kim,J.H., Rabinowitsch,A.I.,
Chowdhury,D., Schildkraut,C.L. and Borowiec,J.A. (2014)
Nucleic Acids Research, 2017, Vol. 45, No. 15 8871
Phosphorylated RPA recruits PALB2 to stalled DNA replication
forks to facilitate fork recovery. J. Cell Biol., 206, 493–507.
33. Ashley,A.K., Shrivastav,M., Nie,J., Amerin,C., Troksa,K.,
Glanzer,J.G., Liu,S., Opiyo,S.O., Dimitrova,D.D., Le,P. et al. (2014)
DNA-PK phosphorylation of RPA32 Ser4/Ser8 regulates replication
stress checkpoint activation, fork restart, homologous recombination
and mitotic catastrophe. DNA Repair (Amst.), 21, 131–139.
34. Lee,D.-H., Pan,Y., Kanner,S., Sung,P., Borowiec,J.A. and
Chowdhury,D. (2010) A PP4 phosphatase complex dephosphorylates
RPA2 to facilitate DNA repair via homologous recombination. Nat.
Struct. Mol. Biol., 17, 365–372.
35. Shi,W., Feng,Z., Zhang,J., Gonzalez-Suarez,I., Vanderwaal,R.P.,
Wu,X., Powell,S.N., Roti Roti,J.L., Gonzalo,S. and Zhang,J. (2010)
The role of RPA2 phosphorylation in homologous recombination in
response to replication arrest. Carcinogenesis, 31, 994–1002.
36. Povlsen,L.K., Beli,P., Wagner,S.A., Poulsen,S.L., Sylvestersen,K.B.,
Poulsen,J.W., Nielsen,M.L., Bekker-Jensen,S., Mailand,N. and
Choudhary,C. (2012) Systems-wide analysis of ubiquitylation
dynamics reveals a key role for PAF15 ubiquitylation in
DNA-damage bypass. Nat. Cell Biol., 14, 1089–1098.
37. Mare´chal,A., Li,J.M., Ji,X.Y., Wu,C.S., Yazinski,S.a., Nguyen,H.D.,
Liu,S., Jime´nez,A.E., Jin,J. and Zou,L. (2014) PRP19 transforms into
a sensor of RPA–ssDNA after DNA damage and drives ATR
activation via a ubiquitin-mediated circuitry.Mol. Cell, 53, 235–246.
38. Elia,A.E.H., Wang,D.C., Willis,N.A., Gygi,S.P., Scully,R. and
Elledge,S.J. (2015) RFWD3-dependent ubiquitination of RPA
regulates repair at stalled replication forks RFWD3-dependent
ubiquitination of RPA regulates repair at stalled replication forks.
Mol. Cell, 60, 280–293.
39. Chan,S.-P., Kao,D.-I., Tsai,W.-Y. and Cheng,S.-C. (2003) The
Prp19p-associated complex in spliceosome activation. Science, 302,
279–282.
40. Song,E.J., Werner,S.L., Neubauer,J., Stegmeier,F., Aspden,J., Rio,D.,
Harper,J.W., Elledge,S.J., Kirschner,M.W. and Rape,M. (2010) The
Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control
reversible ubiquitination at the spliceosome. Genes Dev., 24,
1434–1447.
41. Chanarat,S., Seizl,M. and Stra¨ßer,K. (2011) The Prp19 complex is a
novel transcription elongation factor required for TREX occupancy
at transcribed genes. Genes Dev., 25, 1147–1158.
42. Wan,L. and Huang,J. (2014) The PSO4 protein complex associates
with replication protein a (RPA) and modulates the activation of
ataxia telangiectasia-mutated and RAD3-related (ATR). J. Biol.
Chem., 289, 6619–6626.
43. Abbas,M., Shanmugam,I., Bsaili,M., Hromas,R. and Shaheen,M.
(2014) The role of the human Psoralen 4 (hPso4) complex in
replication stress and homologous recombination. J. Biol. Chem.,
289, 14009–14019.
44. Gong,Z. and Chen,J. (2011) E3 ligase RFWD3 participates in
replication checkpoint control. J. Biol. Chem., 286, 22308–22313.
45. Danielsen,J.M.R., Sylvestersen,K.B., Bekker-Jensen,S.,
Szklarczyk,D., Poulsen,J.W., Horn,H., Jensen,L.J., Mailand,N. and
Nielsen,M.L. (2011) Mass spectrometric analysis of lysine
ubiquitylation reveals promiscuity at site level.Mol. Cell. Proteomics,
10, M110.003590.
46. Pierce,A.J., Johnson,R.D., Thompson,L.H. and Jasin,M. (1999)
XRCC3 promotes homology-directed repair of DNA damage in
mammalian cells. Genes Dev., 15, 2633–2638.
47. Dolinsky,T.J., Nielsen,J.E., McCammon,J.A. and Baker,N.A. (2004)
PDB2PQR: an automated pipeline for the setup of
Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res., 32,
665–667.
48. Baker,N.A., Sept,D., Joseph,S., Holst,M.J. and McCammon,J.A.
(2001) Electrostatics of nanosystems: application to microtubules and
the ribosome. Proc. Natl. Acad. Sci. U.S.A., 98, 10037–10041.
49. Orlicky,S., Tang,X., Willems,A., Tyers,M. and Sicheri,F. (2003)
Structural basis for phosphodependent substrate selection and
orientation by the SCFCdc4 ubiquitin ligase. Cell, 112, 243–256.
50. Liu,S., Chu,J., Yucer,N., Leng,M., Wang,S.-Y., Chen,B.P.C.,
Hittelman,W.N. and Wang,Y. (2011) RING finger and WD repeat
domain 3 (RFWD3) associates with replication protein A (RPA) and
facilitates RPA-mediated DNA damage response. J. Biol. Chem., 286,
22314–22322.
51. Ordureau,A., Mu,C. and Harper,J.W. (2015) Quantifying ubiquitin
signaling.Mol. Cell, 58, 660–676.
52. Wang,H., Guan,J., Wang,H., Perrault,A.R., Wang,Y. and Iliakis,G.
(2001) Replication protein A2 phosphorylation after DNA damage
by the coordinated action of ataxia telangiectasia-mutated and
DNA-dependent protein kinase. Cancer Res., 61, 8554–8563.
53. Shao,R.G., Cao,C.X., Zhang,H., Kohn,K.W., Wold,M.S. and
Pommier,Y. (1999) Replication-mediated DNA damage by
camptothecin induces phosphorylation of RPA by DNA-dependent
protein kinase and dissociates RPA:DNA-PK complexes. EMBO J.,
18, 1397–1406.
54. Adamson,B., Smogorzewska,A., Sigoillot,F.D., King,R.W. and
Elledge,S.J. (2012) A genome-wide homologous recombination screen
identifies the RNA-binding protein RBMX as a component of the
DNA-damage response. Nat. Cell Biol., 14, 1–13.
55. Beli,P., Lukashchuk,N., Wagner,S.A., Weinert,B.T., Olsen,J. V,
Baskcomb,L., Mann,M., Jackson,S.P. and Choudhary,C. (2012)
Proteomic investigations reveal a role for RNA processing factor
THRAP3 in the DNA damage response.Mol. Cell, 46, 1–14.
56. Polo,S.E., Blackford,A.N., Chapman,J.R., Baskcomb,L., Gravel,S.,
Rusch,A., Thomas,A., Blundred,R., Smith,P., Kzhyshkowska,J. et al.
(2012) Regulation of DNA-End resection by hnRNPU-like proteins
promotes DNA double-strand break signaling and repair.Mol. Cell,
45, 505–516.
57. Britton,S., Dernoncourt,E., Delteil,C., Froment,C., Schiltz,O.,
Salles,B., Frit,P. and Calsou,P. (2014) DNA damage triggers SAF-A
and RNA biogenesis factors exclusion from chromatin coupled to
R-loops removal. Nucleic Acids Res., 42, 1–16.
58. Matsuoka,S., Ballif,B.A., Smogorzewska,A., McDonald,E.R.,
Hurov,K.E., Luo,J., Bakalarski,C.E., Zhao,Z., Solimini,N.,
Lerenthal,Y. et al. (2007) ATM and ATR substrate analysis reveals
extensive protein networks responsive to DNA damage. Science, 316,
1160–1166.
59. Bensimon,A., Schmidt,A., Ziv,Y., Elkon,R., Wang,S.-Y., Chen,D.J.,
Aebersold,R. and Shiloh,Y. (2010) ATM-dependent and
-independent dynamics of the nuclear phosphoproteome after DNA
damage. Sci. Signal., 3, rs3.
60. Binz,S.K., Lao,Y., Lowry,D.F. and Wold,M.S. (2003) The
phosphorylation domain of the 32-kDa subunit of replication protein
A (RPA) modulates RPA-DNA interactions: evidence for an
intersubunit interaction. J. Biol. Chem., 278, 35584–35591.
61. Onyango,D.O., Howard,S.M., Neherin,K., Yanez,D.A. and
Stark,J.M. (2016) Tetratricopeptide repeat factor XAB2 mediates the
end resection step of homologous recombination. Nucleic Acids Res.,
44, 5702–5716.
62. Ohi,M.D., Vander Kooi,C.W., Rosenberg,J.A., Chazin,W.J. and
Gould,K.L. (2003) Structural insights into the U-box, a domain
associated with multi-ubiquitination. Nat. Struct. Biol., 10, 250–255.
63. Vander Kooi,C.W., Ohi,M.D., Rosenberg,J.A., Oldham,M.L.,
Newcomer,M.E., Gould,K.L. and Chazin,W.J. (2006) The Prp19
U-box crystal structure suggests a common dimeric architecture for a
class of oligomeric E3 ubiquitin ligases. Biochemistry, 45, 121–130.
64. Jackson,S.P. and Durocher,D. (2013) Regulation of DNA damage
responses by ubiquitin and SUMO.Mol. Cell, 49, 795–807.
65. Polo,S.E. and Jackson,S.P. (2011) Dynamics of DNA damage
response proteins at DNA breaks: a focus on protein modifications.
Genes Dev., 25, 409–433.
66. Panier,S. and Boulton,S.J. (2013) Double-strand break repair: 53BP1
comes into focus. Nat. Rev. Mol. Cell Biol., 15, 7–18.
67. Inano,S., Sato,K., Katsuki,Y., Kobayashi,W., Tanaka,H.,
Nakajima,K., Nakada,S., Miyoshi,H., Knies,K., Takaori-Kondo,A.
et al. (2017) RFWD3-mediated ubiquitination promotes timely
removal of both RPA and RAD51 from DNA damage sites to
facilitate homologous recombination.Mol. Cell, 66, 622–634.e8.
68. Fu,X., Yucer,N., Liu,S., Li,M., Yi,P., Mu,J.-J., Yang,T., Chu,J.,
Jung,S.Y., O’Malley,B.W. et al. (2010) RFWD3-Mdm2 ubiquitin
ligase complex positively regulates p53 stability in response to DNA
damage. Proc. Natl. Acad. Sci. U.S.A., 107, 4579–4584.
69. Grey,M., Du¨sterho¨ft,a, Henriques,J.a and Brendel,M. (1996)
Allelism of PSO4 and PRP19 links pre-mRNA processing with
recombination and error-prone DNA repair in Saccharomyces
cerevisiae. Nucleic Acids Res., 24, 4009–4014.
70. Brendel,M., Bonatto,D., Strauss,M., Revers,L.F., Pungartnik,C.,
Saffi,J. and Henriques,J.A.P. (2003) Role of PSO genes in repair of
8872 Nucleic Acids Research, 2017, Vol. 45, No. 15
DNA damage of Saccharomyces cerevisiae.Mutat. Res. Mutat. Res.,
544, 179–193.
71. Zhang,N., Kaur,R., Akhter,S. and Legerski,R.J. (2009) Cdc5L
interacts with ATR and is required for the S-phase cell-cycle
checkpoint. EMBO Rep., 10, 1029–1035.
72. Feng,S., Zhao,Y., Xu,Y., Ning,S., Hou,W., Hou,M., Gao,G., Ji,J.,
Guo,R. and Xu,D. (2016) Ewing tumor-associated antigen 1 interacts
with replication protein A to promote restart of stalled replication
forks. J. Biol. Chem., 291, 21956–21962.
73. Haahr,P., Hoffmann,S., Tollenaere,M.A.X., Ho,T., Toledo,L.I.,
Mann,M., Bekker-Jensen,S., Ra¨schle,M. and Mailand,N. (2016)
Activation of the ATR kinase by the RPA-binding protein ETAA1.
Nat. Cell Biol., 18, 1196–1207.
74. Lee,Y., Zhou,Q., Chen,J. and Yuan,J. (2016) RPA-binding protein
ETAA1 Is an ATR activator involved in DNA replication stress
response. Curr. Biol., 26, 1–12.
75. Bass,T.E., Luzwick,J.W., Kavanaugh,G., Carroll,C., Dungrawala,H.,
Glick,G.G., Feldkamp,M.D., Putney,R., Chazin,W.J. and Cortez,D.
(2016) ETAA1 acts at stalled replication forks to maintain genome
integrity. Nat. Cell Biol., 18, 1185–1195.
76. Oakley,G.G., Tillison,K., Opiyo,S.A., Glanzer,J.G., Horn,J.M. and
Patrick,S.M. (2009) Physical interaction between replication protein
A (RPA) and MRN: involvement of RPA2 phosphorylation and the
N-terminus of RPA1. Biochemistry, 48, 7473–7481.
77. Feeney,L., Mun˜oz,I.M., Lachaud,C., Toth,R., Appleton,P.L.,
Schindler,D. and Rouse,J. (2017) RPA-mediated recruitment of the
E3 ligase RFWD3 is vital for interstrand crosslink repair and human
health.Mol. Cell, 66, 610–621.
